Esquire Financial FY2025 net income rose 16% to USD 50.82 million

Reuters
Mar 14
Esquire Financial FY2025 net income rose 16% to USD 50.82 million

Esquire Financial reported FY 2025 net income of USD 50.82 million, up 16% from FY 2024. Net interest income rose 22% to USD 121.48 million, while net interest margin was 6.02%. Total assets increased 25% to USD 2.37 billion and loans held for investment rose 26% to USD 1.76 billion, driven by growth in commercial litigation-related lending. Total deposits grew 26% to USD 2.06 billion, and uninsured deposits were USD 685.1 million, or 33.2% of total bank deposits. The company also said it signed a merger agreement with Signature Bancorporation under which Signature shareholders would receive 2.63 Esquire shares per Signature share, implying an aggregate transaction value of about USD 348.4 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Esquire Financial Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-027706), on March 13, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10